| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0d9fe2f1a28bffcf78fea7422b4852d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8282d8d83d506206a4534d357ade9d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b565db69925cf53b44bb353db57f316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7682671290050413b44ea41b27ebea84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5046d67864072096378b224ac775a2b4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate |
2006-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5806c6394a2057c30b48988425536623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_390fda15be7b96045ff8ac6a39366063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f724d21cca2ea98b620e0e33d1bc357c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a9a3101499f9e59fceb665b640854d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45942e1cd58fc6572624353d61c3172c |
| publicationDate |
2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007191304-A1 |
| titleOfInvention |
Methods for performing percutaneous coronary intervention |
| abstract |
Methods for performing percutaneous coronary intervention in a patient in need thereof comprising administering intravenously a bolus comprising an effective amount of enoxaparin sodium to the patient after sheath insertion and prior to the percutaneous coronary intervention are described. Also described are methods for preventing or treating thrombosis, such as thrombotic episodes, in a human percutaneous coronary intervention patient by treating that patient with enoxaparin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102050888-A |
| priorityDate |
2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |